secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2022-03-07T23:59:59+00:00
Accession:  0000950170-22-003002
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix enters $50M common stock purchase agreement with Lincoln Park Capital
------------------------------------------------------------------------------

- Up to $50M of common stock may be sold to Lincoln Park over 36 months at Biodesix's discretion.
- Purchase price based on prevailing market prices with no upper limit per share.
- No warrants, derivatives, financial or business covenants; LPC cannot short or hedge.
- Biodesix issued commitment shares as a fee and can terminate the agreement at any time without cost.
- Net proceeds to be used for growth strategy and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000095017022003002/0000950170-22-003002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000095017022003002/bdsx-20220307.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-003002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer